# A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials

> **NCT05439941** · PHASE2 · TERMINATED · sponsor: **Evelo Biosciences, Inc.** · enrollment: 287 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** EDP1815

## Key facts

- **NCT ID:** NCT05439941
- **Lead sponsor:** Evelo Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-06
- **Primary completion:** 2023-05-25
- **Final completion:** 2023-06-07
- **Target enrollment:** 287 (ACTUAL)
- **Why stopped:** Parent Study (NCT05121480) did not meet the primary endpoint.
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05439941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05439941, "A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05439941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*